Clinical Trial Update: Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nintedanib in patients with advanced non-small cell lung cancer who progressed after up to two prior chemotherapy regimens has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Recurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-08